MedTrace Logo

A Nasal Spray With Glucose Oxidase as a Treatment of Common Cold

NCT01883453 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2015-11-09

Study results available
· View outcomes & findings →

Summary

Healthy persons are invited to participate in the study and are given a home protocol (WURSS21), nasal spray and a sample pin. The included persons are told to make a nasopharyngeal sampling from the nose when they are sure that they have caught a common cold. After the sampling they start to spray and also fill in the records daily. The aim of the study is to investigate whether a nasal spray with glucose oxidase could shorten an episode of common cold.

Conditions

  • Common Cold

Interventions

DEVICE

Glucose oxidase+5%glucose

A hydrogen peroxide producing enzyme

DEVICE

Saline+5%glucose

Isotonic saline + 5% glucose in a bag-on-valve nasal spray device

Sponsors & Collaborators

  • Umeå University

    lead OTHER

Principal Investigators

  • Krister Tano, MD,PhD · Umeå University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-05-31
Completion
2013-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01883453 on ClinicalTrials.gov